[1] SCHFER W，FRIEBE W G，LEINERT H，et al. Non-nucleoside inhibitors of HIV-1 reverse transcriptase：molecular modeling and X-ray structure investigations[J] . J Med Chem，1993，36(6)：726-732. [2] PAUWELS R. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections[J] . Curr Opin Pharmacol，2004，4(5)：437-446. [3] MENG G，CHEN F E. Research progress of HEPT analogs as nonnucleoside HIV-1 reverse transcriptase inhibitors[J] .Chin J Med Chem(中国药物化学杂志)，2004，14(1)：56-64. [4] DE CLERCQ E. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)：past，present，and future[J] . Chemistry ＆ Biodiversity，2004，1(1)：44-64. [5] BENJAHAD A，COURT? K，GUILLEMONT J，et al. 4-benzyl-and 4-benzoyl-3-dimethylaminopyridin-2(1H)- ones，a new family of potent anti-HIV agents：optimization and in vitro evaluation against clini-cally important HIV mutant strains[J] . J Med Chem，2004，47 (22)：5501-5514. [6] BUCKHEIT R W JR，WATSON K，FLIAKAS-BOLTZ V，et al. SJ-3366，a unique and highly potent non- nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2[J] . Antimicrob Agents Chemother，2001，45(2)：393-440. [7] ARTICO M. Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs)：the DABOs family[J] . Drugs Fut，2002，27(2)：159-175. [8] HE Y P，CHEN F，YU X J，et al. Nonnucleoside HIV-1 reverse transcriptaseinhibitors; part 3. Synthesis and antiviralactivity of 5-alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio] -6-(1-naphthylmethyl)pyr-imidin-4(3H)-ones[J] . Bioorg Chem，2004，32(6)：536-548. [9] LOBATO′N E，RODRL′GREZ-BARRIOS F，GAGO F，et al. Synthesis of 3″-substituted TSAO derivatives with anti-HIV-1 and anti-HIV-2 activity through an efficient palladium-catalyzed cross-coupling approach[J] . J Med Chem，2002，45(18)：3934-3945. [10] COCUZZA A J，CHIDESTER D R，CORDOVA B C，et al. 4，1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors[J] . Bioorg Med Chem Lett，2001，11(11)：1389-1392. [11] CORBETT J W，GEARHART L A，KO S S，et al. Novel 2，2-dioxide-4，4-disubstituted-1，3-H-2，1，3-benzo- thiadiazines as non-nucleoside reverse transcriptase inhibitors[J] . Bioorg Med Chem Lett，2000，10(2)：193-195. [12] CORBETT J W，KRESGE K J，PAN S，et al. Trifluoromethyl-containing 3-alkoxymethyl-and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase[J] . Bioorg Med Chem Lett，2001，11(3)：309-312. [13] CHAN J H，HONG J S，HUNTER R N，et al. 2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1[J] . J Med Chem，2001，44(12)：1866-1882. [14] SILVESTRI R，ARTICO M，DE MARTINO G，et al. Simple，short peptide derivatives of a sulfonylindole- carboxamide (L-737，126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations [J] . J Med Chem，2004，47(15)：3892-3896. [15] SILVESGRI R，DE MARTINO G，LA REGINA G，et al. Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations：synthesis and SAR studies[J] . J Med Chem，2003，46(12)：2482-2493. [16] SILVESTRI R，ARTICO M，LA REGINA G，et al. Anti-HIV-1 activity of pyrryl aryl sulfone (PAS) derivatives：synthesis and SAR studies of novel esters and amides at the position 2 of the pyrrole nucleus[J] . Farmaco，2004，59(3)：201-210. [17] LUDOVICI D W，KAVASH R W，KUKLA M J，et al. Evolution of anti-HIV drug candidates. Part 2：Diaryltriazine (DATA) analogues[J] . Bioorg Med Chem Lett，2001，11(17)：2229-2234. [18] LUDOVICI D W，DE CORTE B L，KUKLA M J，et al. Evolution of anti-HIV drug candidates. Part 3：Diarylpyrimidine (DAPY) analogues[J] . Bioorg Med Chem Lett，2001，11(17)：2235-2239. [19] GUILLEMONT J，PASQUIER E，PALANDJIAN P，et al. Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1[J] . J Med Chem，2005, 48(6):2072-2079. [20] HEERES J，DE JONGE M R，KOYMANS L M H，et al. Design，synthesis，and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity[J] . J Med Chem，2005,48(6):1910-1918. [21] RAO A，CARBONE A，CHIMIRRI A，et al. Synthesis and anti-HIV activity of 2，3-diaryl-1，3-thiazolidin- 4-(thi)one derivatives[J] . Farmaco，2002，57(9)：747-751. [22] RAO A，CHIMIRRI A，DE CLERCQ E，et al. Synthesis and anti-HIV activity of 1-(2，6-difluorophenyl)-1H，3H-thiazolo[3，4-a] benzimidazole structurally-related 1，2-substituted benzimi-dazoles[J] . Farma- co，2002，57(10)：819-823. [23] RAO A，BALZARINI J，CARBONE A，et al. Synthesis of new 2，3-diaryl-1，3-thiazolidin-4-ones as anti-HIV agents[J] . Farmaco，2004，59(1)：33-39. [24] RAO A，BALZARINI J，CARBONE A，et al. 2-(2，6-Dihalophenyl)-3-(pyrimidin-2-yl)-1，3-thiazolidin- 4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors[J] . Antiviral Res，2004，63(2)：79-84. [25] SILVESTRI R，ARTICO M，MASSA S，et al. 1-[2-(Diphenylmethoxy)ethyl] -2-methyl-5-nitroimidazole：a potent lead for the design of novel NNRTIs[J] . Bioorg Med Chem Lett，2000，10(3)：253-256. [26] SILVESTRI R，ARTICO M，DE ARTINO G，et al. Synthesis，biological evaluation，and binding mode of novel 1-[2-(diarylmethoxy)ethyl] -2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptase[J] . J Med Chem，2002，45(8)：1567-1576. [27] ARRANZ M E，DIZA J A，INGATE S T，et al. Synthesis and anti-HIV activity of 1，1，3-trioxo-2H，4H- thieno[3，4-e] [1，2，4] -thiadiazines(TTDs)：a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors[J] . Bioorg Med Chem，1999，7(12)：2811-2822. [28] PELEMANS H，ESNOUF R，DE CLERCQ E，et al. Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors[J] . Mol Pharmacol，2000，57(5)：954-960.